Jat JA, Mal P, Kumar D. Renal osteodystrophy in end stage renal failure patients on maintenance haemodialysis. J Clin Exp Nephrol. 2016;01:04.
Flores R, Lopes J, Caridade S. Secondary hyperparathyroidism presenting as a brown tumor: A case report and review of the literature. Cureus. 2023 Jan 16;
DOI: 10.7759/cureus.33820
Niederle BE, Schmidt G, Organ CH, Niederle B. Albert J and His Surgeon: A historical reevaluation of the first parathyroidectomy. J Am Coll Surg. 2006 ;202(1):181–90.
DOI: 10.1016/j.jamcollsurg.2005.03.036
Messina L, Garipoli A, Giordano FM, Ferrari U, Grippo R, Sarli M, et al. A patient with multiple brown tumors due to secondary hyperparathyroidism: A case report. Radiol Case Rep. 2021;16(9):2482–6.
DOI: 10.1016/j.radcr.2021.06.015
Selvi F, Cakarer S, Tanakol R, Guler S, Keskin C. Brown tumour of the maxilla and mandible: a rare complication of tertiary hyperparathyroidism. Dentomaxillofacial Radiology. 2009;38(1):53–8.
DOI: 10.1259/dmfr/81694583
Kampschreur LM, Hoogeveen EK, op den Akker JW, Beutler JJ, Beems T, Dorresteijn LDA, et al. A haemodialysis patient with back pain: brown tumour as a cause of spinal cord compression under cinacalcet therapy. Clin Kidney J. 2010 ;3(3):291–5.
DOI: 10.1093/ndtplus/sfq052
Messina L, Garipoli A, Giordano FM, Ferrari U, Grippo R, Sarli M, et al. A patient with multiple brown tumors due to secondary hyperparathyroidism: A case report. Radiol Case Rep. 2021;16(9):2482–6.
DOI: 10.1016/j.radcr.2021.06.015
Bellorin-Font E, Vasquez-Rios G, Martin KJ. Controversies in the management of secondary hyperparathyroidism in chronic kidney disease. Curr Osteoporos Rep. 2019;17(5):333–42.
DOI: 10.1007/s11914-019-00533-x
Kalathas T, Kalatha T, Boultoukas E. Brown tumors; a possible pitfall in diagnosing metastatic disease. Hell J Nucl Med. 2010;13(1):15–7.
Seyedzadeh A, Tohidi MR, Golmohamadi S, Omrani HR, Seyedzadeh MS, Amiri S, et al. Prevalence of renal osteodystrophy and its related factors among end-stage renal disease patients undergoing hemodialysis: report from Imam Reza Referral hospital of medical university of Kermanshah, Iran. Oman Med J. 2022;37(1):e335–e335.
DOI: 10.5001/omj.2021.120
Jervis L, James M, Howe W, Richards S. Osteolytic lesions: osteitis fibrosa cystica in the setting of severe primary hyperparathyroidism. BMJ Case Rep. 2017;bcr-2017-220603.
DOI: 10.1136/bcr-2017-220603
Misiorowski W, Czajka-Oraniec I, Kochman M, Zgliczyński W, Bilezikian JP. Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism. Endocrine. 2017;58(2):380–5.
DOI: 10.1007/s12020-017-1414-2
Witteveen JE, van Thiel S, Romijn JA, Hamdy NAT. therapy of endocrine disease: Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol. 2013;168(3):R45–53.
DOI: 10.1530/EJE-12-0528
Pal R, Gautam A, Bhadada SK. Role of bisphosphonates in the prevention of postoperative hungry bone syndrome in primary hyperparathyroidism: A meta-analysis and need for randomized controlled trials. Drug Res. 2021;71(02):108–9.
DOI: 10.1055/a-1325-0351